Stocks and Investing Stocks and Investing
Thu, August 31, 2023
Wed, August 30, 2023

Yigal Nochomovitz Maintained (APLS) at Strong Buy with Increased Target to $54 on, Aug 30th, 2023


Published on 2024-10-28 06:12:05 - WOPRAI, Yigal Nochomovitz
  Print publication without navigation


Yigal Nochomovitz of Citigroup, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $45 to $54 on, Aug 30th, 2023.

Yigal has made no other calls on APLS in the last 4 months.



There are 11 other peers that have a rating on APLS. Out of the 11 peers that are also analyzing APLS, 5 agree with Yigal's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Reiterated at Hold and Held Target at $29 on, Wednesday, August 23rd, 2023
  • Anupam Rama of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $60 on, Thursday, August 3rd, 2023
  • Brian Cheng of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $40 on, Tuesday, August 1st, 2023
  • Derek Archila of "Wells Fargo" Maintained at Hold with Decreased Target to $53 on, Thursday, July 20th, 2023
  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $81 on, Friday, May 5th, 2023


These are the ratings of the 6 analyists that currently disagree with Yigal


  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $65 on, Tuesday, August 29th, 2023
  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $82 on, Wednesday, August 23rd, 2023
  • Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $64 on, Wednesday, August 23rd, 2023
  • Justin Kim of "Oppenheimer" Reiterated at Buy on, Wednesday, August 23rd, 2023
  • Colleen Kusy of "Baird" Maintained at Buy with Decreased Target to $70 on, Tuesday, August 1st, 2023
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $89 on, Tuesday, August 1st, 2023
Contributing Sources